nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—Ergonovine—ABCB1—adrenal gland cancer	0.0345	0.475	CrCbGaD
Methylergometrine—Ergotamine—ABCB1—adrenal gland cancer	0.0194	0.267	CrCbGaD
Methylergometrine—Bromocriptine—ABCB1—adrenal gland cancer	0.0187	0.258	CrCbGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00535	0.00577	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00535	0.00576	CbGpPWpGaD
Methylergometrine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00514	0.00554	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00505	0.00544	CbGpPWpGaD
Methylergometrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0049	0.00528	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00484	0.00522	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0047	0.00506	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00457	0.00493	CbGpPWpGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00448	0.00483	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00439	0.00474	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00432	0.00465	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00431	0.00465	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00431	0.00465	CbGpPWpGaD
Methylergometrine—HTR1E—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00423	0.00456	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00421	0.00453	CbGpPWpGaD
Methylergometrine—DRD1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00414	0.00447	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00414	0.00447	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00407	0.00439	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00407	0.00438	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—GNAS—adrenal gland cancer	0.00403	0.00434	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00399	0.0043	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GNRHR—adrenal gland cancer	0.00393	0.00424	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00392	0.00422	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00391	0.00422	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00384	0.00414	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—GNAS—adrenal gland cancer	0.0038	0.0041	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00376	0.00406	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00375	0.00404	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GNRHR—adrenal gland cancer	0.00371	0.004	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00369	0.00398	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00369	0.00398	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00369	0.00398	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00366	0.00394	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00356	0.00384	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—TSHR—adrenal gland cancer	0.00355	0.00383	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00348	0.00375	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00345	0.00372	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00344	0.00371	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00336	0.00362	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—TSHR—adrenal gland cancer	0.00335	0.00362	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—TSHR—adrenal gland cancer	0.00329	0.00354	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00324	0.0035	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0032	0.00345	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00316	0.00341	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00302	0.00326	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00285	0.00308	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00274	0.00296	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—POMC—adrenal gland cancer	0.00271	0.00293	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00258	0.00279	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—POMC—adrenal gland cancer	0.00256	0.00276	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00255	0.00275	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00244	0.00263	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00241	0.00259	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00238	0.00257	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00237	0.00256	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GNRH1—adrenal gland cancer	0.00236	0.00254	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00235	0.00253	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00231	0.00249	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0023	0.00248	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00228	0.00246	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00225	0.00242	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00223	0.00241	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GNRH1—adrenal gland cancer	0.00222	0.0024	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00221	0.00239	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00218	0.00235	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00217	0.00234	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CDC42—adrenal gland cancer	0.00216	0.00233	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SPRY2—adrenal gland cancer	0.00215	0.00232	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00215	0.00232	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00215	0.00232	CbGpPWpGaD
Methylergometrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00213	0.0023	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TSHR—adrenal gland cancer	0.0021	0.00226	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0021	0.00226	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00209	0.00225	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00208	0.00225	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—GNAS—adrenal gland cancer	0.00207	0.00223	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CDC42—adrenal gland cancer	0.00204	0.0022	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SPRY2—adrenal gland cancer	0.00203	0.00219	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00203	0.00219	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00202	0.00218	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TSHR—adrenal gland cancer	0.00198	0.00214	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00198	0.00213	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MEN1—adrenal gland cancer	0.00197	0.00213	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00197	0.00213	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—GNAS—adrenal gland cancer	0.00195	0.0021	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00191	0.00206	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00191	0.00206	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00189	0.00204	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00187	0.00201	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MEN1—adrenal gland cancer	0.00186	0.00201	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00186	0.002	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00183	0.00197	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00181	0.00195	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00173	0.00187	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00173	0.00186	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00169	0.00182	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00169	0.00182	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00166	0.00179	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00164	0.00177	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00163	0.00176	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00162	0.00175	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00161	0.00174	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.0016	0.00173	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	0.0016	0.00172	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—POMC—adrenal gland cancer	0.00153	0.00165	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PRKACA—adrenal gland cancer	0.00151	0.00162	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00151	0.00162	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.0015	0.00162	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0015	0.00162	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00147	0.00158	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00146	0.00158	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—POMC—adrenal gland cancer	0.00145	0.00156	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PRKACA—adrenal gland cancer	0.00142	0.00153	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00142	0.00153	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00142	0.00153	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0014	0.00151	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—POMC—adrenal gland cancer	0.00139	0.0015	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00139	0.00149	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00134	0.00144	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00134	0.00144	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00132	0.00143	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—POMC—adrenal gland cancer	0.00131	0.00142	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00131	0.00141	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00129	0.00139	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00129	0.00139	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CDC42—adrenal gland cancer	0.00128	0.00138	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00127	0.00137	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00127	0.00137	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00126	0.00136	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	0.00124	0.00133	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IGF2—adrenal gland cancer	0.00123	0.00133	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GNAS—adrenal gland cancer	0.00122	0.00132	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00122	0.00131	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00121	0.00131	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CDC42—adrenal gland cancer	0.00121	0.0013	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.0012	0.00129	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.0012	0.00129	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IGF1R—adrenal gland cancer	0.00119	0.00128	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.00116	0.00126	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IGF2—adrenal gland cancer	0.00116	0.00125	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	0.00116	0.00125	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GNAS—adrenal gland cancer	0.00115	0.00124	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00115	0.00124	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00113	0.00122	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IGF1R—adrenal gland cancer	0.00112	0.00121	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00112	0.00121	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00112	0.00121	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.00112	0.00121	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.0011	0.00118	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00108	0.00117	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00105	0.00113	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00103	0.00111	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TERT—adrenal gland cancer	0.00103	0.00111	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00102	0.0011	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000996	0.00107	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000982	0.00106	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000981	0.00106	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000971	0.00105	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TERT—adrenal gland cancer	0.000967	0.00104	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000938	0.00101	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000937	0.00101	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000919	0.00099	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000902	0.000972	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—BAD—adrenal gland cancer	0.000892	0.000962	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000892	0.000962	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000888	0.000957	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000886	0.000956	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000865	0.000933	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000852	0.000919	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00085	0.000917	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—BAD—adrenal gland cancer	0.000841	0.000907	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000836	0.000901	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—POMC—adrenal gland cancer	0.000822	0.000887	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000821	0.000886	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000819	0.000883	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000813	0.000877	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—BRAF—adrenal gland cancer	0.000812	0.000876	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EGFR—adrenal gland cancer	0.000787	0.000849	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—POMC—adrenal gland cancer	0.000776	0.000837	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000772	0.000833	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—BRAF—adrenal gland cancer	0.000766	0.000826	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000752	0.000811	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EGFR—adrenal gland cancer	0.000742	0.000801	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000727	0.000784	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000725	0.000781	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000718	0.000775	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000715	0.000771	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000709	0.000765	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000701	0.000756	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000683	0.000737	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000677	0.000731	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000661	0.000713	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000661	0.000712	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000632	0.000681	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000621	0.00067	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000607	0.000654	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000603	0.00065	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000587	0.000633	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000585	0.00063	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.00058	0.000625	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000574	0.000619	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000569	0.000613	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000565	0.00061	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000554	0.000597	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000529	0.000571	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000529	0.000571	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000527	0.000568	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000525	0.000566	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000508	0.000547	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000503	0.000543	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000495	0.000534	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000491	0.000529	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000487	0.000525	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000484	0.000522	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000478	0.000515	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—adrenal gland cancer	0.000465	0.000501	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000463	0.000499	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000456	0.000492	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.00045	0.000486	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—adrenal gland cancer	0.000439	0.000473	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000437	0.000471	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000423	0.000456	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000423	0.000456	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000395	0.000425	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—adrenal gland cancer	0.00039	0.000421	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.00039	0.000421	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000385	0.000416	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000374	0.000403	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—adrenal gland cancer	0.000368	0.000397	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000368	0.000396	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000345	0.000372	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000339	0.000365	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000335	0.000361	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000326	0.000351	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000324	0.00035	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000288	0.00031	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000279	0.0003	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000273	0.000295	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000258	0.000278	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000242	0.000261	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000233	0.000252	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	0.00023	0.000248	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000229	0.000247	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000221	0.000238	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000217	0.000234	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000192	0.000207	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	0.000185	0.0002	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	0.000161	0.000173	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000157	0.000169	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000125	0.000135	CbGpPWpGaD
